MedCity News December 14, 2021
Jordan Feldman

A blended navigation model that includes a transformed pharmacy benefits offering is the industry’s best opportunity for overall cost reduction in an employer space that desperately needs it.

What happens when you take a simplistic view to a pointed discussion? In the case of care navigation, you get polarizing opinions in a sector that’s not accustomed to sharp debate.

Recently, Glen Tulman, CEO of Transcarent, and Rajeev Singh, CEO of Accolade, exchanged blows on the right approach to care navigation. Glen proclaimed navigation as an obsolete “middleman,” and described it as paving a way through shattered glass rather than working to pick up the pieces. Rajeev came at this from a different perspective, as the leader of the care navigation...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Employer, Healthcare System, Insurance, Pharma, Pharma / Biotech, Provider
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Hospital mergers are leading to higher prices. Will regulators step in?
Steep Ozempic, Wegovy prices face fresh scrutiny from officials
How Mass. hospitals move forward with intention on health equity
Turning point: COVID-era hospital reporting set to end

Share This Article